Together with PhenoSense GT™ (combination phenotype/genotype drug resistance test), PhenoSense Entry™ provides the most complete picture of resistance to antiretroviral medications.
PhenoSense Entry™ is the only commercially available phenotypic test for measuring susceptibility to entry inhibitors.
Click here to view the Medical Necessity and Authorization of Services Form for PhenoSense Entry™.
Click on the links below to learn more about PhenoSense Entry™.
